Literature DB >> 2140380

A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.

J L Fudge1, P J Perry, M J Garvey, M W Kelly.   

Abstract

Tricyclic antidepressants with clinically significant amounts of anticholinergic activity can adversely affect memory and cognitive functioning. The study evaluated the effect of two non-anticholinergic antidepressants, fluoxetine and trazodone, on immediate and short-term memory in clinically depressed outpatients. The results of this study demonstrated that neither drug affected the depressed patients' cognitive skills as measured by the Guild memory test (digit span and paired associations) during their treatment and recovery. The only factor that was useful in predicting an improvement in cognitive functioning was the change in the measures of depression (Hamilton Rating Scale for Depression and Clinical Global Impression) with time.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140380     DOI: 10.1016/0165-0327(90)90079-n

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

Authors:  M Hotopf; G Lewis; C Normand
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 2.  Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.

Authors:  Ai Leng Khoo; Hui Jun Zhou; Monica Teng; Liang Lin; Ying Jiao Zhao; Lay Beng Soh; Yee Ming Mok; Boon Peng Lim; Kok Peng Gwee
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 3.  Fluoxetine versus other types of pharmacotherapy for depression.

Authors:  A Cipriani; P Brambilla; T Furukawa; J Geddes; M Gregis; M Hotopf; L Malvini; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 4.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

5.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

Review 6.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

7.  The effects of trazodone on human cognition: a systematic review.

Authors:  Ana Mafalda Gonçalves Gonçalo; Maria Augusta Vieira-Coelho
Journal:  Eur J Clin Pharmacol       Date:  2021-06-07       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.